Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Resistente 'E. coli' overgedragen door fecestransplantatie
nov 2019 | Antibioticaresistentie, Bacteriële infecties, Transplantatie